dr. snyder on mainstays of treatment in polycythemia vera
Published 4 years ago • 215 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:46
dr. snyder on ruxolitinib in patients with myelofibrosis
-
8:03
goals of therapy in polycythemia vera
-
1:11
dr. hoffman on the current treatment paradigm of polycythemia vera
-
6:15
treating leukocytosis in polycythemia vera
-
4:31
ruxolitinib for treatment of polycythemia vera
-
4:04
polycythemia vera: monitoring patients
-
1:49
dr. verstovsek on benefit of ruxolitinib in polycythemia vera
-
6:09
signs of progressive polycythemia vera
-
1:01
dr. ruben mesa on advancements in polycythemia vera
-
2:18
dr. snyder on the quest to revolutionize management of myelofibrosis
-
7:45
suspecting polycythemia vera: challenges in diagnosis
-
1:51
dr. snyder on transplant updates in myelofibrosis
-
6:42
differentiating between myeloproliferative neoplasms
-
1:19
dr. snyder discusses emerging agents in myelofibrosis
-
0:50
dr. snyder on how ruxolitinib and fedratinib may pave the way to transplant in myelofibrosis
-
19:49
what is the current standard of care in treating polycythemia vera (pv)?
-
4:25
srdan verstovsek, md, on predicting resistance to hydroxyurea therapy in polycythemia vera
-
5:42
an update on revive: rusfertide in patients with polycythemia vera
-
1:39
upcoming agents in et and pv